Non-specific inhibition of imipramine binding argues against an endogenous ligand
- 1 May 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 181 (1-2) , 9-15
- https://doi.org/10.1016/0014-2999(90)90239-3
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- WHO Pilot Study on the Validity of Imipramine Platelet Receptor Binding Sites as a Biological Marker of Endogenous DepressionPharmacopsychiatry, 1988
- Endogenous Ligands for High-Affinity Recognition sites of Psychotropic DrugsAnnual Review of Pharmacology and Toxicology, 1988
- Evaluation of the potential of thermospray liquid chromatographyy—mass spectrometry in neurochemistryJournal of Chromatography A, 1987
- Purification and properties of a human plasma endogenous modulator for the platelet tricyclic binding/serotonin transport complexBiochimica et Biophysica Acta (BBA) - General Subjects, 1987
- [3H]imipramine displacement and 5HT uptake inhibition by tryptoline derivatives: In rat brain 5-methoxytryptoline is not the autacoid for [3H]imipramine recognition sitesEuropean Journal of Pharmacology, 1986
- Comparative Ontogenesis of Brain Tryptamine, Serotonin, and TryptophanJournal of Neurochemistry, 1985
- Inhibition of synaptosomal 5‐[3H]hydroxytryptamine uptake by endogenous factor(s) in human bloodFEBS Letters, 1984
- Fluorometric Determination of Tryptophan and Its Brain Indoleamine Metabolites by Ion-Pair HPLCJournal of Liquid Chromatography, 1983
- Human platelets possess high-affinity binding sites for 3H-imipramineEuropean Journal of Pharmacology, 1979
- A new mass fragmentographic method for the simultaneous analysis of tryptophan, tryptamine, indole-3-acetic acid, serotonin, and 5-hydroxyindole-3-acetic acid in the same sample of rat brainAnalytical Biochemistry, 1979